Antimicrobial Agents Practice Questions

Q: Which of the following is NOT a beta-lactam antibiotic?

Vancomycin. **Explanation:** The core concept tested here is the structural classification of cell wall synthesis inhibitors. **Beta-lactam antibiotics** are characterized by the presence of a four-membered beta-lactam ring in their molecular structure, which is essential for their antibacterial activity [3]. **Why Vancomycin is the correct answer:** While **Vancomycin** also inhibits bacterial cell wall synthesis, it is a **Glycopeptide** antibiotic, not a beta-lactam [1]. It works by binding to the **D-Ala-D-Ala** terminus of nascent peptidoglycan pentapeptide, sterically hindering the elongation of the peptidoglycan chain [3]. It lacks the beta-lactam ring and therefore does not bind to Penicillin-Binding Proteins (PBPs). **Analysis of incorrect options:** * **Amoxicillin (Option A):** An Aminopenicillin belonging to the **Penicillin** group (classic beta-lactams). * **Aztreonam (Option B):** A **Monobactam**, which is a unique beta-lactam where the ring is not fused to another ring [2]. It is notable for being safe in patients with penicillin allergies (except ceftazidime allergy). * **Ceftriaxone (Option C):** A 3rd-generation **Cephalosporin**, which is a major class of beta-lactam antibiotics [4]. **NEET-PG High-Yield Pearls:** 1. **Mechanism of Beta-lactams:** They inhibit the enzyme **transpeptidase**, preventing the cross-linking of peptidoglycan layers [2], [3]. 2. **Vancomycin Resistance:** Occurs via the replacement of D-Ala-D-Ala with **D-Ala-D-Lac** (seen in VRSA/VRE). 3. **Red Man Syndrome:** A common side effect of Vancomycin due to histamine release (minimized by slow infusion), not to be confused with a true IgE-mediated allergy. 4. **Spectrum:** Aztreonam is active only against **Gram-negative aerobes**, while Vancomycin is active only against **Gram-positive** organisms (including MRSA) [1].

Q: Which antiretroviral therapy (ART) drug is an entry inhibitor?

Enfuvirtide. ### Explanation **Correct Option: A. Enfuvirtide** Enfuvirtide is a fusion inhibitor, a sub-class of **entry inhibitors**. It works by binding to the **gp41** subunit of the viral envelope glycoprotein. This prevents the conformational change required for the fusion of the HIV envelope with the host cell membrane, thereby blocking viral entry. It is unique because it is administered subcutaneously. **Incorrect Options:** * **B. Abacavir:** This is a **Nucleoside Reverse Transcriptase Inhibitor (NRTI)**. It acts by competitively inhibiting the reverse transcriptase enzyme and causing DNA chain termination. (Note: Associated with HLA-B*5701 hypersensitivity). * **C. Efavirenz:** This is a **Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)**. It binds directly to the reverse transcriptase enzyme at a site distinct from the active site, inducing a conformational change that inactivates the enzyme. * **D. Amprenavir:** This is a **Protease Inhibitor (PI)**. It inhibits the viral protease enzyme (HIV-1 protease), preventing the cleavage of polyprotein precursors into mature, infectious virions. **High-Yield Clinical Pearls for NEET-PG:** * **Entry Inhibitors:** There are two main types: 1. **Fusion Inhibitors:** Enfuvirtide (binds gp41). 2. **CCR5 Antagonists:** Maraviroc (binds host CCR5 receptor; requires a "tropism test" before use). * **Attachment Inhibitor:** Fostemsavir (binds gp120) is a newer agent in this category. * **Post-attachment Inhibitor:** Ibalizumab (monoclonal antibody binding CD4). * **Mnemonic for Enfuvirtide:** En**fu**virtide prevents **Fu**sion by binding gp**41** (4+1 = 5, "Fu" sounds like Five).

Q: Which of the following drugs can be used for the prophylaxis of meningococcal meningitis?

Ciprofloxacin. **Explanation:** The goal of prophylaxis in meningococcal meningitis (*Neisseria meningitidis*) is to eradicate the nasopharyngeal carrier state in close contacts of an index case, thereby preventing secondary transmission. **Why Ciprofloxacin is Correct:** **Ciprofloxacin** (a fluoroquinolone) is a preferred agent for adult prophylaxis because a single oral dose (500 mg) effectively eliminates the carrier state. It is highly effective, easy to administer, and reaches sufficient concentrations in respiratory secretions. Other first-line alternatives include **Rifampin** (drug of choice in children, though it requires multiple doses) and **Ceftriaxone** (given as a single IM injection, preferred in pregnancy). **Why Other Options are Incorrect:** * **Chloramphenicol (A):** While it crosses the blood-brain barrier and is used for *treating* bacterial meningitis in patients with severe penicillin allergy, it is not used for prophylaxis due to its potential for serious bone marrow toxicity (aplastic anemia). * **Erythromycin (B):** This macrolide has poor activity against *N. meningitidis* and does not reliably eradicate the nasopharyngeal carrier state. * **Tetracycline (C):** These are bacteriostatic agents that do not achieve the necessary efficacy in the nasopharynx to be recommended for meningococcal prophylaxis. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) for Prophylaxis:** Rifampin (600 mg BID for 2 days). * **DOC in Pregnancy:** Ceftriaxone (250 mg IM, single dose). * **Adult Alternative:** Ciprofloxacin (500 mg PO, single dose). * **Note:** Prophylaxis is indicated for "close contacts" (household members, daycare contacts, or healthcare workers exposed to respiratory secretions), not for casual contacts. * **H. influenzae Prophylaxis:** Rifampin is also the drug of choice here, but the dosing schedule differs from meningococcal protocols.

Q: Which of the following drugs is most effective against an organism producing aminoglycoside inactivating enzymes?

Amikacin. The correct answer is **Amikacin**. The primary mechanism of bacterial resistance to aminoglycosides is the production of **aminoglycoside-modifying enzymes (AMEs)**, such as transferases (acetylases, adenylases, and phosphorylases). These enzymes modify the drug molecule, preventing it from binding to the 30S ribosomal subunit. **Amikacin** is a semisynthetic derivative of kanamycin. Its unique chemical structure features a long L-hydroxyaminobutyryl amide (HABA) side chain that sterically hinders the attack of most aminoglycoside-inactivating enzymes [1]. Consequently, Amikacin maintains its potency against many strains that are resistant to other aminoglycosides. It is often reserved for serious nosocomial infections where multi-drug resistance is suspected. **Why other options are incorrect:** * **Streptomycin:** This is the oldest aminoglycoside and is highly susceptible to enzymatic inactivation. It has a narrow spectrum and is primarily used for tuberculosis and plague. * **Gentamicin and Tobramycin:** These are frequently used for Gram-negative infections but are common substrates for AMEs. Bacteria that develop resistance to Gentamicin often show cross-resistance to Tobramycin, as both lack the protective side chain found in Amikacin. **High-Yield NEET-PG Pearls:** * **Spectrum:** Amikacin has the **widest antibacterial spectrum** among aminoglycosides. * **Resistance:** If a Gram-negative organism is resistant to Amikacin, it is typically resistant to all other aminoglycosides. * **Ototoxicity:** While all aminoglycosides are ototoxic, Amikacin is specifically associated with **auditory damage** (cochleotoxicity) more than vestibular damage. * **Rule of Thumb:** Aminoglycosides are "Oxygen-dependent"—they are ineffective against anaerobes because their uptake into the bacteria requires an oxygen-dependent active transport mechanism.

Q: Which one of the following is effective in the treatment of brucellosis?

Rifampicin. **Explanation:** Brucellosis is a zoonotic infection caused by *Brucella* species, which are **facultative intracellular organisms**. Effective treatment requires antibiotics with excellent intracellular penetration and activity in the acidic environment of macrophages. **Why Rifampicin is Correct:** Rifampicin is a bactericidal drug that inhibits bacterial DNA-dependent RNA polymerase. It has **excellent intracellular penetration**, making it a cornerstone in brucellosis management. According to WHO guidelines, the standard treatment for uncomplicated brucellosis is a combination of **Doxycycline (for 6 weeks) plus Rifampicin (for 6 weeks)** or Doxycycline plus Streptomycin. **Why Other Options are Incorrect:** * **Amphotericin B:** This is a polyene antifungal agent used for systemic fungal infections (e.g., Mucormycosis, Leishmaniasis). It has no antibacterial activity. * **Ketoconazole:** This is an imidazole antifungal that inhibits ergosterol synthesis. It is used for superficial fungal infections and Cushing’s syndrome but is ineffective against bacteria. * **Penicillin:** *Brucella* species are inherently resistant to penicillins. Furthermore, penicillins have poor intracellular penetration, making them ineffective against intracellular pathogens like *Brucella*. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Doxycycline + Streptomycin (considered slightly more effective than Doxycycline + Rifampicin in preventing relapse). * **Pregnancy/Children:** Rifampicin + Trimethoprim-Sulfamethoxazole (TMP-SMX) is the preferred regimen, as tetracyclines and aminoglycosides are generally avoided. * **Neurobrucellosis:** Requires a triple regimen (Ceftriaxone + Rifampicin + Doxycycline). * **Diagnostic Test:** Standard Agglutination Test (SAT) is the most common serological test; Rose Bengal Plate Test is used for screening.

Q: What is the DOC for Extrapulmonary cryptococcal infection without CNS involvement?

Fluconazole. **Explanation:** The management of Cryptococcosis depends on the site of infection and the immune status of the patient. For **extrapulmonary cryptococcal infection without CNS involvement** (e.g., isolated pulmonary or soft tissue infection) in non-immunocompromised patients, **Fluconazole** is the Drug of Choice (DOC). **Why Fluconazole is correct:** Fluconazole is highly effective, has excellent oral bioavailability, and a superior safety profile compared to polyenes. For mild-to-moderate non-meningeal disease, it is administered at a dose of 400 mg daily for 6–12 months. It inhibits the fungal enzyme 14α-demethylase, preventing ergosterol synthesis. **Why other options are incorrect:** * **Amphotericin B:** This is the DOC for **disseminated or CNS cryptococcosis** (Cryptococcal Meningitis) as part of induction therapy. It is not used as monotherapy for mild extrapulmonary cases due to its significant nephrotoxicity. * **Flucytosine:** This is never used as monotherapy due to the rapid development of resistance. It is used strictly as an **adjunct** to Amphotericin B during the induction phase of meningitis. * **Azoles:** While Fluconazole is an azole, "Azoles" is too broad an option. Specifically, Fluconazole is preferred over Ketoconazole or Itraconazole due to better penetration and fewer side effects. **High-Yield NEET-PG Pearls:** 1. **Cryptococcal Meningitis DOC:** Induction with **Amphotericin B + Flucytosine** (2 weeks), followed by Consolidation and Maintenance with **Fluconazole**. 2. **Antigen Detection:** CrAg (Cryptococcal Antigen) via Lateral Flow Assay (LFA) is the most sensitive rapid diagnostic test. 3. **Staining:** **India Ink** preparation shows a "haloing" effect due to the thick polysaccharide capsule. 4. **Prophylaxis:** Primary prophylaxis is generally not recommended; however, secondary prophylaxis (maintenance) is mandatory in AIDS patients until immune reconstitution occurs.

Q: Peripheral neuritis is a complication of which drug?

Isoniazid. **Explanation:** **Isoniazid (INH)** is the correct answer because it interferes with the metabolism of **Pyridoxine (Vitamin B6)**. INH is chemically similar to pyridoxine and promotes its excretion in the urine. Additionally, it inhibits the enzyme *pyridoxine phosphokinase*, which converts B6 into its active form (pyridoxal phosphate). This deficiency leads to **peripheral neuropathy**, characterized by "glove and stocking" paresthesia [1]. This side effect is more common in "slow acetylators" and patients with pre-existing risks like diabetes, alcoholism, or malnutrition [1]. **Analysis of Incorrect Options:** * **Ethambutol:** Its most characteristic side effect is **Retrobulbar Neuritis**, which presents as decreased visual acuity and red-green color blindness. It does not typically cause peripheral nerve damage. * **Rifampicin:** Known for causing **hepatotoxicity** and a harmless **orange-red discoloration** of body fluids (urine, sweat, tears). It can also cause a "flu-like syndrome" if taken intermittently [4]. * **Pyrazinamide:** The most common side effects are **hyperuricemia** (leading to gout) and hepatotoxicity [3]. It is the most hepatotoxic drug among the first-line ATT. **High-Yield Clinical Pearls for NEET-PG:** * **Prevention:** Peripheral neuritis can be prevented by co-administering **Prophylactic Pyridoxine (10 mg/day)** [1]. * **Treatment:** If neuritis has already developed, the dose of Pyridoxine is increased to **100 mg/day**. * **Metabolism:** INH is metabolized by **Acetylation** (Phase II reaction) [2]. Slow acetylators are at higher risk for neuropathy, while fast acetylators are at higher risk for hepatotoxicity.

Q: Which tissue schizontocide prevents relapse of vivax malaria?

Primaquine. **Explanation:** The correct answer is **Primaquine**. **1. Why Primaquine is correct:** *Plasmodium vivax* and *Plasmodium ovale* have a unique life cycle stage called **hypnozoites**—dormant forms that remain in the liver (exoerythrocytic stage). These hypnozoites can "wake up" months or years later, causing a clinical **relapse**. Primaquine is the prototype **tissue schizontocide** that effectively kills these hepatic stages. It is the only drug (along with the newer Tafenoquine) used for the **radical cure** of vivax malaria to prevent recurrence. **2. Why other options are incorrect:** * **Chloroquine:** It is a potent **blood schizontocide**. While it is the drug of choice for treating the acute erythrocytic phase of malaria, it has no effect on the latent liver stages (hypnozoites). * **Quinine:** Another blood schizontocide used primarily for severe or chloroquine-resistant malaria. Like chloroquine, it cannot prevent relapses. * **Pyrimethamine:** This is a folate antagonist (DHFR inhibitor) used as a **slow-acting blood schizontocide** and a sporontocide. It does not eliminate hypnozoites. **3. High-Yield NEET-PG Pearls:** * **G6PD Deficiency:** Before prescribing Primaquine, patients **must** be screened for G6PD deficiency. The drug causes oxidative stress, leading to **acute hemolysis** in deficient individuals. * **Pregnancy:** Primaquine is **contraindicated** in pregnancy because the fetus is relatively G6PD deficient. * **Gametocidal Action:** Primaquine is also highly effective against the gametocytes of all species, including *P. falciparum*, thereby preventing the transmission of malaria to mosquitoes. * **Tafenoquine:** A long-acting analog of Primaquine that can be given as a single dose for radical cure.

Q: Which drug interferes with pyridoxine metabolism?

Isoniazid (INH). **Isoniazid (INH)** is the correct answer because it is a structural analogue of **Pyridoxine (Vitamin B6)**. It interferes with B6 metabolism through two primary mechanisms:1. It inhibits the enzyme **pyridoxine phosphokinase**, which converts pyridoxine into its active form, pyridoxal-5-phosphate (PLP).2. It reacts with PLP to form **isoniazid-pyridoxal hydrazones**, which are rapidly excreted in the urine.Since PLP is a vital cofactor for the synthesis of neurotransmitters like GABA, its deficiency leads to **peripheral neuropathy** (the most common side effect) [1] and, in rare cases, CNS toxicity/seizures [1].**Analysis of Incorrect Options:** * **Tetracycline:** Acts by inhibiting the 30S ribosomal subunit. Its major side effects involve bone/teeth discoloration and GI upset, not vitamin interference.* **Erythromycin:** A macrolide that inhibits the 50S ribosomal subunit. It is known for causing motilin-like GI effects and cholestatic jaundice.* **Rifampicin:** Inhibits DNA-dependent RNA polymerase. Its high-yield side effects include orange-colored body fluids and potent induction of Cytochrome P450 enzymes.**High-Yield Clinical Pearls for NEET-PG:** * **Prophylaxis:** To prevent neuropathy, INH is co-administered with **10–50 mg/day of Pyridoxine** [1].* **Risk Groups:** Malnourished individuals, alcoholics, diabetics [1], and **slow acetylators** (who have higher plasma levels of INH) [1] are at increased risk.* **Acute Toxicity:** In cases of INH overdose (presenting with seizures), intravenous Pyridoxine is the specific antidote.* **Sideroblastic Anemia:** INH can also cause this because PLP is a cofactor for ALA synthase, the rate-limiting enzyme in heme synthesis.

Question 1

Which of the following is NOT a beta-lactam antibiotic?

Accepted Answer

Vancomycin

Answer

Amoxicillin

Answer

Aztreonam

Answer

Ceftriaxone

Question 2

Which antiretroviral therapy (ART) drug is an entry inhibitor?

Accepted Answer

Enfuvirtide

Answer

Abacavir

Answer

Efavirenz

Answer

Amprenavir

Question 3

Which of the following drugs can be used for the prophylaxis of meningococcal meningitis?

Accepted Answer

Ciprofloxacin

Answer

Chloramphenicol

Answer

Erythromycin

Answer

Tetracycline

Question 4

Which of the following drugs is most effective against an organism producing aminoglycoside inactivating enzymes?

Accepted Answer

Amikacin

Answer

Streptomycin

Answer

Gentamicin

Answer

Tobramycin

Question 5

Which one of the following is effective in the treatment of brucellosis?

Accepted Answer

Rifampicin

Answer

Amphotericin

Answer

Ketoconazole

Answer

Penicillin

Question 6

A 45-year-old male presents with fever, cough, and anorexia. Sputum is positive for AFB. He is being treated with isoniazid, rifampicin, pyrazinamide, and ethambutol. What is the primary reason for administering multidrug therapy in tuberculosis?

Accepted Answer

To delay the development of drug resistance.

Answer

To broaden the antimicrobial spectrum.

Answer

To prevent toxin release from the organism.

Answer

To reduce drug toxicity.

Question 7

What is the DOC for Extrapulmonary cryptococcal infection without CNS involvement?

Accepted Answer

Fluconazole

Answer

Amphotericin B

Answer

Flucytosine

Answer

Azoles

Question 8

Peripheral neuritis is a complication of which drug?

Accepted Answer

Isoniazid

Answer

Ethambutol

Answer

Rifampicin

Answer

Pyrazinamide

Question 9

Which tissue schizontocide prevents relapse of vivax malaria?

Accepted Answer

Primaquine

Answer

Quinine

Answer

Pyrimethamine

Answer

Chloroquine

Question 10

Which drug interferes with pyridoxine metabolism?

Accepted Answer

Isoniazid (INH)

Answer

Tetracycline

Answer

Erythromycin

Answer

Rifampicin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?